Loading...
Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update
Physicians treating patients affected by nonmuscle-invasive bladder cancer (NMIBC) have been in shock during the last six years since manufacturing restrictions on the production of the first-option medicine, Mycobacterium bovis Bacillus Calmette-Guérin (BCG), have resulted in worldwide shortages. T...
Na minha lista:
| Udgivet i: | Immunotargets Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7025668/ https://ncbi.nlm.nih.gov/pubmed/32104666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S202006 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|